Gene Query: HLA-DRB4

Dataset Description Geneva Score
Transcriptome of Stabilin-1 siRNA transfected human monocytes 248.44
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 151.0
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 101.26
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 94.0
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 93.99
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 87.17
Transcriptional profile in human S. haematobium infection 72.37
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 68.83
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 64.03
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 52.99
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 51.99
Transcriptomic analysis of human macrophages in 3D 51.64
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 49.32
MHC Transcriptomic landscape at haplotype-specific resolution 48.45
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 48.2
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 45.26
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 44.26
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 43.56
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 42.31
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 42.31
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 42.29
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 40.86
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 40.09
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 40.09
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 39.91
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 39.15
Dysregulated immune system networks in war veterans with PTSD 38.9
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 38.6
FOXP1 orchestration of ASD-relevant signaling pathways. 37.08
RNA-Seq in neutrophils from Antiphospholipid Syndrome 36.33
Transcriptome Profiling of Human Primary Monocytes 35.58
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 35.54
Primate transcript and protein expression levels evolve under compensatory selection pressures 35.3
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 34.09
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 34.09
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 33.89
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 32.82
Transcriptional effect of ETV1 knockdown in melanoma cells 32.08
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 31.04
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 30.87
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 30.28
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 29.47
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 27.61
Transcriptional profiles of normal human mature B cells 27.57
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 27.29
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 27.23
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 27.07
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 26.76
CD74 role in transcription regulation 26.49
CD74 role in transcription regulation [RNA-seq] 26.49
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 26.27
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 25.39
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 25.36
Trascriptome of thyroid cancer-induced macrophages 25.05
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 25.0
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 24.73
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 24.73
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 24.19
Transcriptional responses of melanoma cells to BRAF inhibition 23.99
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 23.81
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 23.81
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 23.46
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 23.21
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 23.21
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 23.18
Effect of Hotair overexpression in human breast cancer cell lines 23.04
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 23.0
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 22.91
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 22.62
Aging-associated patterns in the expression of human endogenous retroviruses 21.78
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 21.64
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 20.76
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 20.69
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 20.66
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 20.47
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 20.43
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 20.35
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 20.25
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 20.01
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 19.14
ZIKV infection of monocytes activates inflammasome pathways 18.98
Polarized B -cell functions 18.94
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 18.66
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 18.65
Transcriptional profiling of microglia; current state of the art and future perspectives 18.59
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 18.39
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 18.32
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 18.15
Be1 and Be2 B cells are transcriptionally distinct 18.09
RNA-seq of stable and unstable section of human atherosclerotic plaques 17.71
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 17.64
Gene expression changes associated with resistance to tagraxofusp (SL-401) 17.28
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 17.05
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 17.05
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 16.93
Unique features and clinical importance of acute alloreactive immune responses 16.57
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 16.42
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 16.33
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 15.46
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 15.46
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 15.45
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 15.17
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 15.11
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 14.95
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 14.95
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 14.79
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 14.66
Human Treg NaCl stimulation 14.3
Gene expression profiling of papillary thyroid cancer from central and invasive regions 14.27
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 14.21
quanTIseq: quantifying immune contexture of human tumors 14.21
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 13.97
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 13.97
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 13.84
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 13.81
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 13.8
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 13.33
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 13.15
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 12.87
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 12.84
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 12.77
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 12.67
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 12.55
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 12.43
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 12.29
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 12.22
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 12.12
Clinker: visualizing fusion genes detected in RNA-seq data 11.88
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 11.88
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 11.88
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 11.84
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 11.83
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 11.73
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 11.59
Non-coding regions are the main source of tumor-specific antigens [human] 11.39
Non-coding regions are the main source of tumor-specific antigens 11.39
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 11.22
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 11.19
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 11.12
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 11.06
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 10.91
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 10.8
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 10.78
Dermal endothelial cells of type 2 diabetic patients 10.63
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 10.57
Effects of rFVIIIFc on human macrophages 10.48
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 10.48
Generation and functional characterization of MDSC-like cells 10.47
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 10.42
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 10.42
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 10.42
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 10.39
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 10.39
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 10.39
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 10.39
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 10.23
Single-Cell Genotyping of Transcriptomes 10.11
RNA-seq of Single-Cell Genotyping of Transcriptomes 10.11
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 10.05
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 10.01
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 9.87
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 9.87
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 9.85
Widespread intronic polyadenylation diversifies immune cell transcriptomes 9.72
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 9.67
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 9.67
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 9.57
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 9.57
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 9.54
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 9.54
Global gene expression profile of dasatinib-resistant RCH-ACV cells 9.44
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 9.4
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 9.38
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 9.16
The Genetic Landscape of Diamond-Blackfan Anemia 9.02
Intron retention induced by microsatellite expansions as a disease biomarker. 8.9
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 8.8
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 8.65
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 8.58
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 8.58
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 8.58
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 8.43
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 8.37
Molecular analysis of renal cell carcinoma with unclassfied histology 8.3
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 8.3
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 8.11
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 8.11
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 8.09
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 8.05
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 7.95
Reprogrammed myeloid cell transcriptomes in NSCLC 7.94
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 7.86
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 7.43
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 7.39
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 7.34
Transcriptome analysis reveals differential splicing events in IPF lung tissue 7.3
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 7.21
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 7.21
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 7.21
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 7.19
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 7.14
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 7.13
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 6.97
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 6.97
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 6.91
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 6.91
Transcriptome of human white and brown adipose tissue biopsies 6.87
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 6.85
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 6.81
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 6.81
Anti-inflammatory effect of indoleacrylic acid (IA) 6.76
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 6.73
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 6.69
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 6.58
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.54
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 6.43
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 6.43
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 6.43
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 6.34
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 6.31
CD86 regulates a pro-survival signal in myeloma cells 6.31
Defective structural RNA processing in relapsing-remitting multiple sclerosis 6.24
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 6.2
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 6.2
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 6.17
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 6.17
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 6.15
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 6.15
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 6.11
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 6.07
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 6.05
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 6.02
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 5.99
Transcriptomes of human monocytes after ex vivo exposure to uric acid 5.97
oxLDL exposed trained monocytes 5.94
Transcriptomes of oxLDL exposed trained monocytes 5.94
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 5.91
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 5.88
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 5.87
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 5.8
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 5.8
Frailty in middle age is associated with race-specific changes to the transcriptome. 5.75
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 5.74
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 5.73
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 5.73
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 5.69
Gene expression activation in CLL mediated by MSCs contact 5.68
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 5.67
Hepatosplenic T cell lymphoma 5.67
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 5.67
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 5.63
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 5.61
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 5.56
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 5.31
The Glioma-Infiltrating T Cell Receptor Repertoire 5.27
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 5.21
RNA-sequencing of human tendon after injury 5.08
Transcriptome analysis of peripheral blood monocytes 5.0
Short and Long RNA sequencing of human mature erythrocytes 4.98
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 4.97
Single cell transcriptome of peritoneal cells 4.95
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 4.94
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 4.88
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 4.88
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 4.84
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 4.83
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 4.82
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 4.81
A novel target of EZH1/2 for treatment of mantle cell lymphoma 4.72
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 4.67
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 4.52
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 4.52
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 4.42
Landscape of H3K4me3 in human CD19 cells 4.41
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 4.36
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 4.36
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 4.35
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 4.35
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 4.33
Gene expression of collecting duct carcinoma of the kidney 4.31
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 4.31
The role of m6A/m-RNA methylation in stress response regulation 4.31
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 4.31
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 4.28
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 4.22
Differential gene expression of human melanoma cells [RNA-seq] 4.18
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 4.18
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 4.17
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 4.13
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 4.13
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 4.12
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 4.12
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 4.12
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 4.11
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 4.06
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 4.04
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 4.01
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 3.98
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 3.7
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 3.7
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 3.65
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.63
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 3.63
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 3.63
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 3.52
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.5
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 3.46
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 3.42
Transcriptome analysis of CNS leukemia 3.42
Total RNA-Seq data from leukemic patients with complex structural variants 3.41
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 3.39
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.31
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.31
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.25
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 3.16
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.13
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 3.12
LncRNA expression profiling of ischemic stroke patients 3.08
Morphological and molecular characterization of human dermal lymphatic collectors 3.07
Fibroblasts in cholesteatoma activate osteoclasts. 3.05
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 3.02
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 2.93
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 2.92
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 2.9
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.86
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 2.84
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.83
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 2.78
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 2.77
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 2.76
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 2.76
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 2.71
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.71
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.7
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 2.66
A single cell reference map for human blood and tissue T cell activation 2.63
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 2.61
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.6
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 2.57
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 2.52
Neonatal and adult human testis defined at the single-cell level 2.51
RNA-seq data 2.46
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 2.45
A Unique Epigenomic Landscape Defines Human Erythropoiesis 2.44
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 2.44
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 2.39
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 2.34
JAK dependent survival of ALK- ALCL 2.34
Transcriptome of diurnal human blood neutrophils 2.33
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 2.31
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 2.3
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 2.23
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.23
RNA-seq of primary patient AML samples 2.18
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 2.14
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 2.12
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.05
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 2.02
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.98
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.96
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 1.95
Zone dependent distinctive gene expression profile of the normal human liver tissue 1.94
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 1.92
Evaluating pre-clinical models for studying NASH driven HCC. 1.92
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.92
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.91
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 1.9
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 1.9
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 1.87
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 1.87
Global analysis of alternative splicing regulated by RBM10 1.85
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 1.84
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.83
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.81
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 1.81
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 1.74
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 1.74
Expression analysis of the TAF1 syndrome 1.74
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 1.71
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 1.71
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 1.68
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.63
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 1.62
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 1.62
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.61
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 1.61
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.6
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 1.59
Human T-cell lymphoblastic lymphoma samples and control thymuses 1.54
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 1.54
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.52
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.52
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.52
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.49
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.49
An acquired vulnerability of drug resistant melanoma with therapeutic potential 1.48
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 1.48
Alagille_Nodder 1.47
RNA Seq of Alagille liver biopsies 1.47
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.47
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.47
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 1.45
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.44
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 1.43
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 1.43
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.42
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 1.36
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 1.35
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 1.34
Single-cell analysis of adult human ovary using 10X genomics 1.33
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 1.33
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.32
Leucegene: ALL sequencing 1.3
Proteomics identifies a marker signature of MAPKi resistance in melanoma 1.29
CircRNAome diversity in human mature B-cells, T-cells and monocytes 1.28
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.28
Expression patterns in chronic thromboembolic pulmonary hypertension 1.27
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 1.26
NAPRT activation of macrophages 1.23
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.23
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.21
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.2
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.19
RNA-seq in endometrial stromal tumors 1.19
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.15
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.12
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 1.11
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.09
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 1.08
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 1.08
The DNA methylation landscape of human melanoma [RNA-Seq] 1.0
The DNA methylation landscape of human melanoma 1.0
Transcriptomic analysis of frontal fibrosing alopecia 0.97
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 0.94
BACH2 in human plasma cell fate decision 0.94
Gene expression profile difference among renal location in a stone former 0.9
Transcriptomes in healthy and CHB fetal hearts 0.9
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 0.88
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 0.87
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.87
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 0.86
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.84
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 0.82
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 0.77
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 0.77
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.76
Bone marrow derived human B cells [normal proB] 0.68
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.66
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.66
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.65
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 0.64
Nonpregnant and term pregnant human myometrial tissues 0.64
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.62
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.62
Transcriptome analysis of human lung epithelial cells 0.57
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.56
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 0.55
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.55
Specific molecular signatures underlie response to decitabine in CMML 0.55
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 0.53
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.52
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.52
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.47
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.46
Human Treg IFNg/IL-10 subpopulations 0.44
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.42
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 0.42
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.41
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.39
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.39
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.39
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.36
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.35
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.31
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.27
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.27
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 0.25
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 0.25
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 0.25
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.24
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.23
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 0.19
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 0.18
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.18
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.17
Tpl-2 small molecule project 0.15
Tpl-2 and MEK small molecule inhibitors 0.15
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.14
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.12
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.12
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.12
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.11
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.08
The gene expression profiles of gallbladder cancer 0.07
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 0.03
Macrophage Ad5f35 PhenoMap 0.03
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.02
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.02
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.01
The expression profiles of GBC liver metastasis 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation